With the analysis among 477 patents, we discovered top 68 key players by total patent application. Idera Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Biologicals SA are dominant in this area. They take 32.91% of the total patent filing.
Idera Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 67
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Biologicals SA
Basel-Stadt, Switzerland
Patent: 30
VentiRx Pharmaceuticals, Inc.
Washington, United States
Patent: 27
3M Innovative Properties Co.
Minnesota, United States
Patent: 17
California, United States
Patent: 15
Infinity Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 14
California, United States
Patent: 12
Washington, United States
Patent: 12
With the analysis among 11 patents, we discovered top 4 start-ups by total patent application. Checkmate Pharmaceuticals, Inc., Institut National de la Santé et de la Recherche Médicale, Hibercell, Inc. are active in this area.
Checkmate Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 4
Institut National de la Santé et de la Recherche Médicale
New York, United States
Patent: 2
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 1
With the analysis among related 183 patents applied in the last 5 years. We discover 57 most active companies in this area. The fast-growing Ambrx, Inc., Nektar Therapeutics, The University of Chicago take 20.22% of patent filing during this period.
California, United States
Patent: 15
California, United States
Patent: 12
The University of Chicago
Illinois, United States
Patent: 10
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 10
Suzhou Zelgen Biopharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 8
Shanghai Zejing Pharmaceutical Technology Co Ltd
Shanghai Shi, China
Patent: 7
F. Hoffmann-La Roche Ltd.
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 7
Board of Trustees of the Leland Stanford Junior University
California, United States
Patent: 6
Yonsei Industry-Academic Cooperation Foundation
With the analysis among related 183 patents in last 5 years, we discover 34 new entrants. Ambrx, Inc., Nektar Therapeutics, Boehringer Ingelheim International GmbH are the most active new entrants in this area.
California, United States
Patent: 15
California, United States
Patent: 12
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 10
Suzhou Zelgen Biopharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 8
Shanghai Zejing Pharmaceutical Technology Co Ltd
Shanghai Shi, China
Patent: 7
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 7
Yonsei Industry-Academic Cooperation Foundation
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 4
Silverback Therapeutics, Inc.
Washington, United States
Patent: 4
Mirexus Biotechnologies, Inc.
With the analysis among 243 patents, we discovered top 24 universities and scientific research institutions by total patent application. The Johns Hopkins University, President & Fellows of Harvard College, The University of Chicago are dominant in this area. They take 34.57% of the total patent filing.
The Johns Hopkins University
President & Fellows of Harvard College
Massachusetts, United States
Patent: 16
The University of Chicago
Illinois, United States
Patent: 15
Texas, United States
Patent: 9
The Scripps Research Institute
California, United States
Patent: 8
New Hampshire, United States
Patent: 5
Beijing Shi, China
Patent: 5
Connecticut, United States
Patent: 4
University of Kansas Medical Center